Home › NCT07291245

Kawasaki MATCH Trial

Kawasaki MATCH: A Clinical Decision Support Tool to Detect KD

Who can join

30 Days – 17 Years · All sexes

Inclusion Criteria:

* Measured or subjective fever for \>= 3 calendar days
* One measured fever \>= 38.0 C (home or in ED)
* One or more clinical feature of Kawasaki Disease including:
* Rash
* Conjunctival injection
* Oropharyngeal changes
* Extremity changes (erythema, edema, desquamation)
* Cervical adenopathy (\>=1.5cm)
* Infants \< 6 months of age with \>= 7 days of fever eligible even if none of the above clinical features
* Requires IV/phlebotomy for clinical evaluation

Exclusion Criteria:

* Congenital or Acquired Immune function
* Genetic disorders
* Current systemic steroid, immunosuppression, or chemotherapy treatment (not including inhaled steroids)

About the study

Evaluating the impact of a machine-learning clinical decision support tool on provider practice when evaluating febrile patients with Kawasaki Disease (KD) and non-KD illnesses.

What is being tested

• Kawasaki MATCH (other)

Sponsor: University of California, San Diego · Participants: 200 · Started: Mar 1, 2025

Contact the study team

• Michael A Gardiner, MD · Phone: 949-310-4808

Official record on ClinicalTrials.gov — NCT07291245

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.